DBVTDBV Technologies S.A.

$495M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$256,578+2.1% YoY

Gross Profit

$91,20035.5% margin

Operating Income

-$30M-11622.2% margin

Net Income

-$29M-11327.9% margin

EPS (Diluted)

$-8.60

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$34M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$198M

Total Liabilities

$16M

Stockholders' Equity

$182M

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$256,578	$251,318	+2.1%
Gross Profit	$91,200	$110,469	-17.4%
Operating Income	-$30M	-$27M	-8.5%
Net Income	-$29M	-$27M	-9.3%

DBVT FY 2014 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena